BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27992425)

  • 21. Congenital heart diseases and their association with the variant distribution features on susceptibility genes.
    Su W; Zhu P; Wang R; Wu Q; Wang M; Zhang X; Mei L; Tang J; Kumar M; Wang X; Su L; Dong N
    Clin Genet; 2017 Mar; 91(3):349-354. PubMed ID: 27426723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel compound heterozygous TBX5 variants may induce hypoplastic left heart syndrome.
    Miyao N; Hirono K; Hata Y; Yoshimura N; Ichida F
    Pediatr Int; 2019 Jun; 61(6):607-609. PubMed ID: 31215120
    [No Abstract]   [Full Text] [Related]  

  • 23. TBX5 loss-of-function mutation contributes to atrial fibrillation and atypical Holt-Oram syndrome.
    Guo DF; Li RG; Yuan F; Shi HY; Hou XM; Qu XK; Xu YJ; Zhang M; Liu X; Jiang JQ; Yang YQ; Qiu XB
    Mol Med Rep; 2016 May; 13(5):4349-56. PubMed ID: 27035640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new mutation in the TBX5 gene in Holt-Oram syndrome: two cases in the same family and prenatal diagnosis.
    Atik T; Dervisoglu H; Onay H; Ozkinay F; Cogulu O
    J Trop Pediatr; 2014 Jun; 60(3):257-9. PubMed ID: 24408148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Holt-Oram syndrome because of the novel TBX5 mutation c.481A>C.
    Koçak Eker H; Altunoglu U; Toksoy G; Kayserili H
    Clin Dysmorphol; 2016 Oct; 25(4):192-4. PubMed ID: 27552067
    [No Abstract]   [Full Text] [Related]  

  • 26. TBX5 mutations in non-Holt-Oram syndrome (HOS) malformed hearts.
    Reamon-Buettner SM; Borlak J
    Hum Mutat; 2004 Jul; 24(1):104. PubMed ID: 15221798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TBX5 variants and cardiac phenotype: A systematic review of the literature and a novel variant.
    Møller Nielsen AK; Dehn AM; Hjortdal V; Larsen LA
    Eur J Med Genet; 2024 Apr; 68():104920. PubMed ID: 38336121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-Specific TBX5-G125R Variant Induces Profound Transcriptional Deregulation and Atrial Dysfunction.
    van Ouwerkerk AF; Bosada FM; van Duijvenboden K; Houweling AC; Scholman KT; Wakker V; Allaart CP; Uhm JS; Mathijssen IB; Baartscheer T; Postma AV; Barnett P; Verkerk AO; Boukens BJ; Christoffels VM
    Circulation; 2022 Feb; 145(8):606-619. PubMed ID: 35113653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a novel TBX5 c.755 + 1 G > A variant and related pathogenesis in a family with Holt-Oram syndrome.
    Wang DG; Dong XS; Xiong Y; Li ZM; Xie YJ; Liang SH; Huang TH
    Am J Med Genet A; 2022 Jan; 188(1):58-70. PubMed ID: 34490705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of novel TBX5 T-box mutations associated with Holt-Oram syndrome.
    Boogerd CJ; Dooijes D; Ilgun A; Mathijssen IB; Hordijk R; van de Laar IM; Rump P; Veenstra-Knol HE; Moorman AF; Barnett P; Postma AV
    Cardiovasc Res; 2010 Oct; 88(1):130-9. PubMed ID: 20519243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TBX5 mutations and congenital heart disease: Holt-Oram syndrome revealed.
    Mori AD; Bruneau BG
    Curr Opin Cardiol; 2004 May; 19(3):211-5. PubMed ID: 15096952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contiguous gene deletion of TBX5 and TBX3 leads to a varible phenotype with combined features of Holt-Oram and ulnar-mammary syndromes.
    Alby C; Bessieres B; Bieth E; Attie-Bitach T; Fermont L; Citony I; Razavi F; Vekemans M; Escande F; Manouvrier S; Malan V; Amiel J
    Am J Med Genet A; 2013 Jul; 161A(7):1797-802. PubMed ID: 23713051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-box genes and retinoic acid signaling regulate the segregation of arterial and venous pole progenitor cells in the murine second heart field.
    De Bono C; Thellier C; Bertrand N; Sturny R; Jullian E; Cortes C; Stefanovic S; Zaffran S; Théveniau-Ruissy M; Kelly RG
    Hum Mol Genet; 2018 Nov; 27(21):3747-3760. PubMed ID: 30016433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel exons in the tbx5 gene locus generate protein isoforms with distinct expression domains and function.
    Yamak A; Georges RO; Sheikh-Hassani M; Morin M; Komati H; Nemer M
    J Biol Chem; 2015 Mar; 290(11):6844-56. PubMed ID: 25623069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type-I umbilical-systemic shunt with abnormal connection to azygos vein in fetus with de-novo TBX5 mutation related to Holt-Oram syndrome.
    Achiron R; Har-Toov J; Kivilevitch Z
    Ultrasound Obstet Gynecol; 2024 May; 63(5):709-711. PubMed ID: 38197531
    [No Abstract]   [Full Text] [Related]  

  • 36. Tbx5 is required for forelimb bud formation and continued outgrowth.
    Rallis C; Bruneau BG; Del Buono J; Seidman CE; Seidman JG; Nissim S; Tabin CJ; Logan MP
    Development; 2003 Jun; 130(12):2741-51. PubMed ID: 12736217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contiguous gene deletion of TBX5 and TBX3: report of another case.
    Forzano F; Foley PA; Keane MR; Brain CE; Smith GD; Yates RW; Ellershaw D; Calder AD; Scott RH
    Clin Dysmorphol; 2018 Jan; 27(1):6-8. PubMed ID: 28961683
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic Analyses Identified a SALL4 Gene Mutation Associated with Holt-Oram Syndrome.
    Li B; Chen S; Sun K; Xu R; Wu Y
    DNA Cell Biol; 2018 Apr; 37(4):398-404. PubMed ID: 29461882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Congenital extremity anomalies with a TBX5 pathogenic variant in consecutive IVF assisted pregnancies: a case report of Holt-Oram Syndrome.
    Sobh O; O'Sullivan R; Mahoney MJ; Kleinman G
    J Obstet Gynaecol; 2022 Apr; 42(3):524-526. PubMed ID: 34159885
    [No Abstract]   [Full Text] [Related]  

  • 40. Phenotype of a patient with contiguous deletion of TBX5 and TBX3: expanding the disease spectrum.
    Bogarapu S; Bleyl SB; Calhoun A; Viskochil D; Saarel EV; Everitt MD; Frank DU
    Am J Med Genet A; 2014 May; 164A(5):1304-9. PubMed ID: 24664963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.